Listening...

Search Results

No Results

    See all results

    Sorry, I don't understand. Please try again
    1. United States/
    2. New VOYAGER PAD Analysis Confirms Consistent Benefit of XARELTO® (rivaroxaban) Plus Aspirin Following Lower Extremity Revascularization (LER)

    New VOYAGER PAD Analysis Confirms Consistent Benefit of XARELTO® (rivaroxaban) Plus Aspirin Following Lower Extremity Revascularization (LER)

    March 5, 2023
    March 5, 2023

    Download the PDF